Abstract
Radiopharmaceutical chemistry has addressed the issue of biomolecular chemistry, and radiopharmaceuticals are unique in their ability to monitor receptor binding sites and enzymes. The future of diagnostic and therapeutic nuclear medicine, to study the in vivo metabolism, is focused on the use of radiolabeled protein fragments, peptide structures and DNA chains. These radiolabeled molecules represent a substantial change in the paradigms of the pharmaceutical development by employing, as a source of pharmaceuticals, capabilities of our own body, instead of considering it as a simple test-tube where strange molecules interact. Research on biomolecules complexed to radioactive metals, like Tc- 99m, Re-188, Lu-177 and Y-90, that do not alter the molecular specificity, is a topic of world interest in radiopharmaceutical investigations. Some perspectives and achievements on the preparation and analysis of main diagnostic and therapeutic radiopharmaceuticals of the third generation are presented.
Keywords: Radiolabeled biomolecules, Radiopharmaceuticals, Technetium-99m, Rhenium-188, Lutetium-177, Yttrium-90
Current Pharmaceutical Analysis
Title: Third Generation Radiopharmaceuticals for Imaging and Targeted Therapy
Volume: 2 Issue: 4
Author(s): Guillermina Ferro-Flores, Consuelo Arteaga de Murphy and Laura Melendez-Alafort
Affiliation:
Keywords: Radiolabeled biomolecules, Radiopharmaceuticals, Technetium-99m, Rhenium-188, Lutetium-177, Yttrium-90
Abstract: Radiopharmaceutical chemistry has addressed the issue of biomolecular chemistry, and radiopharmaceuticals are unique in their ability to monitor receptor binding sites and enzymes. The future of diagnostic and therapeutic nuclear medicine, to study the in vivo metabolism, is focused on the use of radiolabeled protein fragments, peptide structures and DNA chains. These radiolabeled molecules represent a substantial change in the paradigms of the pharmaceutical development by employing, as a source of pharmaceuticals, capabilities of our own body, instead of considering it as a simple test-tube where strange molecules interact. Research on biomolecules complexed to radioactive metals, like Tc- 99m, Re-188, Lu-177 and Y-90, that do not alter the molecular specificity, is a topic of world interest in radiopharmaceutical investigations. Some perspectives and achievements on the preparation and analysis of main diagnostic and therapeutic radiopharmaceuticals of the third generation are presented.
Export Options
About this article
Cite this article as:
Ferro-Flores Guillermina, Arteaga de Murphy Consuelo and Melendez-Alafort Laura, Third Generation Radiopharmaceuticals for Imaging and Targeted Therapy, Current Pharmaceutical Analysis 2006; 2 (4) . https://dx.doi.org/10.2174/157341206778699555
DOI https://dx.doi.org/10.2174/157341206778699555 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protective Effect of Dietary Potassium against Cardiovascular Damage in Salt-Sensitive Hypertension: Possible Role of its Antioxidant Action
Current Vascular Pharmacology Readjusting the Glucocorticoid Balance: An Opportunity for Modulators of 11β -Hydroxysteroid Dehydrogenase Type 1 Activity?
Endocrine, Metabolic & Immune Disorders - Drug Targets Phytochemical and Pharmacological Insight on Sesamol: An Updated Review
Current Bioactive Compounds Beta-Blocker Therapy for Septic Cardiac Shock: Fiction Or Realism?
Current Drug Therapy Adenosine A2A Receptor Antagonists and Parkinsons Disease: State of the Art and Future Directions
Current Pharmaceutical Design Turning Foes to Friends: Knocking Down Diabetes Associated SGLT2 Transporters and Sustaining Life
Current Diabetes Reviews Cytokines as Anti-Angiogenic Agents in Haematological Malignancies
Current Cancer Drug Targets Update on Medical and Surgical Management of Intracerebral Hemorrhage
Reviews on Recent Clinical Trials Midazolam Plus Haloperidol as Adjuvant Analgesics to Morphine in Opium Dependent Patients: A Randomized Clinical Trial
Current Drug Abuse Reviews The Management and Outcomes of Pharmacological Treatments for Tinnitus
Current Neuropharmacology Drugs Affecting Blood Pressure Variability: An Update
Current Pharmaceutical Design Albumin Infusion Therapy in Stroke, Sepsis and the Critically Ill
Current Nutrition & Food Science Experimental Rodent Models of Vascular Dementia: A Systematic Review
CNS & Neurological Disorders - Drug Targets Adverse Drug Reactions in Critical Care Settings: A Systematic Review
Current Drug Safety Ion Channel Architecture of the Renal Microcirculation
Current Hypertension Reviews In Vitro Human Hepatocyte-Based Experimental Systems for the Evaluation of Human Drug Metabolism, Drug-Drug Interactions, and Drug Toxicity in Drug Development
Current Topics in Medicinal Chemistry Toll-like Receptor 4 Mediates LPS-Induced Release of Nitric Oxide and Tumor Necrosis Factor-α by Embryonal Cardiomyocytes: Biological Significance and Clinical Implications in Human Pathology
Current Pharmaceutical Design Function and Pharmacology of Spinally-Projecting Sympathetic Pre-Autonomic Neurones in the Paraventricular Nucleus of the Hypothalamus
Current Neuropharmacology Isometric Handgrip Effects on Hypertension
Current Hypertension Reviews The Use of Thiazides in Chronic Kidney Disease
Current Hypertension Reviews